Alvaetra Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.12 M
as on 16-11-2024
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.10 M
as on 16-11-2024
- Revenue 0.18%
(FY 2023)
- Profit 93.77%
(FY 2023)
- Ebitda 25.92%
(FY 2023)
- Net Worth -0.48%
(FY 2023)
- Total Assets -0.18%
(FY 2023)
About Alvaetra Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M.
The company has closed loans amounting to ₹0.10 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vidyut Shah and Radhika Shah serve as directors at the Company.
- CIN/LLPIN
U24230MH1986PTC040989
- Company No.
040989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Alvaetra Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidyut Shah  | Director | 12-Jun-2014 | Current |
| Radhika Shah | Director | 25-Apr-2018 | Current |
Financial Performance of Alvaetra Laboratories.
Alvaetra Laboratories Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 0.18% increase. The company also saw a substantial improvement in profitability, with a 93.77% increase in profit. The company's net worth dipped by a decrease of 0.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alvaetra Laboratories?
In 2023, Alvaetra Laboratories had a promoter holding of 54.58% and a public holding of 45.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V S International Private LimitedActive 27 years 5 monthsVidyut Shah and Radhika Shah are mutual person
- Pearim Pharmaceuticals Private LimitedActive 44 years 3 months
Vidyut Shah and Radhika Shah are mutual person
- Saurabh Desai Exports Private LimitedActive 27 years 7 months
Vidyut Shah and Radhika Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 08 Dec 1986 | ₹0.10 M | Satisfied |
How Many Employees Work at Alvaetra Laboratories?
Unlock and access historical data on people associated with Alvaetra Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alvaetra Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alvaetra Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
